| # | Drug | Count |
|---|---|---|
| 0 | RIVAROXABAN | 142 |
| 1 | APIXABAN | 69 |
| 2 | ASPIRIN | 65 |
| 3 | ASPIRIN 325 MG | 63 |
| 4 | ASPIRIN 81 MG | 63 |
| 5 | FUROSEMIDE | 57 |
| 6 | DABIGATRAN ETEXILATE | 55 |
| 7 | DABIGATRAN ETEXILATE MESYLATE | 52 |
| 8 | PREDNISONE | 42 |
| 9 | CLOPIDOGREL | 39 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | ETHIODIZED OIL | 28 | 0.0216 |
| 1 | ANDEXANET ALFA | 7 | 0.0099 |
| 2 | COAGULATION FACTOR VIIA (RECOMBINANT) | 8 | 0.0030 |
| 3 | FOSCARNET SODIUM | 11 | 0.0027 |
| 4 | EDOXABAN TOSYLATE | 12 | 0.0018 |
| 5 | AMPHOTERICIN B | 17 | 0.0013 |
| 6 | GANCICLOVIR SODIUM | 12 | 0.0011 |
| 7 | VANCOMYCIN HYDROCHLORIDE | 9 | 0.0011 |
| 8 | APIXABAN | 69 | 0.0010 |
| 9 | ALTEPLASE | 15 | 0.0010 |
| # | Drug class | Count |
|---|---|---|
| 0 | Factor Xa Inhibitor [EPC] | 211 |
| 1 | Nonsteroidal Anti-inflammatory Drug [EPC] | 107 |
| 2 | Corticosteroid [EPC] | 98 |
| 3 | Platelet Aggregation Inhibitor [EPC] | 65 |
| 4 | Loop Diuretic [EPC] | 60 |
| 5 | Angiotensin 2 Receptor Blocker [EPC] | 53 |
| 6 | Proton Pump Inhibitor [EPC] | 45 |
| 7 | HMG-CoA Reductase Inhibitor [EPC] | 41 |
| 8 | Kinase Inhibitor [EPC] | 39 |
| 9 | Insulin Analog [EPC] | 33 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Melanin Synthesis Inhibitor [EPC] | 3 | 0.0026 |
| 1 | Nucleoside Analog Antifungal [EPC] | 3 | 0.0021 |
| 2 | Interleukin-6 Antagonist [EPC] | 1 | 0.0015 |
| 3 | Interleukin-5 Antagonist [EPC] | 1 | 0.0015 |
| 4 | Lipid-based Polyene Antifungal [EPC] | 17 | 0.0013 |
| 5 | Radiographic Contrast Agent [EPC] | 33 | 0.0013 |
| 6 | Anthracycline Topoisomerase Inhibitor [EPC] | 3 | 0.0012 |
| 7 | Human Blood Coagulation Factor [EPC] | 1 | 0.0012 |
| 8 | Hypoxia-inducible Factor Prolyl Hydroxylase Inhibitor [EPC] | 2 | 0.0009 |
| 9 | Phosphodiesterase 3 Inhibitor [EPC] | 5 | 0.0008 |